| P50 | author | Venugopal Nair | Q41477302 |
| | Jeremy P. Kamil | Q55755049 |
| | Nikolaus Osterrieder | Q89444083 |
| | Sascha Trapp | Q40436106 |
| P2093 | author name string | B Karsten Tischer | |
| | Daniel Schumacher | |
| | Mark S Parcells | |
| | Pankaj M Kumar | |
| P2860 | cites work | The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown | Q24519071 |
| | Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 |
| | One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 |
| | Secondary structure of vertebrate telomerase RNA | Q28138961 |
| | The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation | Q40680048 |
| | Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins | Q40885714 |
| | The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses | Q41012360 |
| | The role of alpha v-integrins in tumour progression and metastasis | Q41084428 |
| | Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes | Q41228429 |
| | STUDIES ON FOWL PARALYSIS (NEUROLYMPHOMATOSIS GALLINARUM) : II. TRANSMISSION EXPERIMENTS. | Q41840636 |
| | Virus specific syngeneic killing of reticuloendotheliosis virus transformed cell line target cells by spleen cells. | Q44371863 |
| | Pathogenesis of Marek's disease virus infection | Q45738484 |
| | Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli | Q45856655 |
| | The chicken telomerase RNA gene: conservation of sequence, regulatory elements and synteny among viral, avian and mammalian genomes | Q46726207 |
| | High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. | Q50754124 |
| | Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. | Q53417588 |
| | Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. | Q53851296 |
| | Telomerase beyond telomeres | Q63384203 |
| | Activation of telomerase in human lymphocytes and hematopoietic progenitor cells | Q71746792 |
| | Telomerase modulates expression of growth-controlling genes and enhances cell proliferation | Q73322990 |
| | The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors | Q74635344 |
| | Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style | Q28140555 |
| | Comparative functional study of the viral telomerase RNA based on natural mutations | Q28243648 |
| | The RNA component of human telomerase | Q28288330 |
| | Identification of a specific telomere terminal transferase activity in Tetrahymena extracts | Q28306745 |
| | A survey of telomerase activity in human cancer | Q29614858 |
| | An efficient recombination system for chromosome engineering in Escherichia coli | Q29615038 |
| | A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA | Q29615197 |
| | A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end | Q29615761 |
| | STUDIES ON FOWL PARALYSIS (NEUROLYMPHOMATOSIS GALLINARUM) : I. CLINICAL FEATURES AND PATHOLOGY. | Q30494883 |
| | Characterization of reticuloendotheliosis virus-transformed avian T-lymphoblastoid cell lines infected with Marek's disease virus | Q31145050 |
| | Meq: an MDV-specific bZIP transactivator with transforming properties | Q32057148 |
| | vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus | Q33788825 |
| | Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant | Q33826716 |
| | ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency | Q33838198 |
| | Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a | Q33987363 |
| | Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells | Q34057890 |
| | Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses | Q34078505 |
| | Telomeres and their control | Q34090772 |
| | The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression | Q34166733 |
| | Telomerase contributes to tumorigenesis by a telomere length-independent mechanism | Q34188701 |
| | Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus | Q34478563 |
| | Telomerase RNA structure and function: implications for dyskeratosis congenita. | Q34547087 |
| | The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection. | Q35891871 |
| | Regulated expression of telomerase activity in human T lymphocyte development and activation | Q36366852 |
| | Status of Marek's disease virus in established lymphoma cell lines: herpesvirus integration is common | Q36638916 |
| | Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication | Q37416184 |
| | Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). | Q37621813 |
| | Telomerase RNA expression during progression of gastric cancer | Q38466711 |
| | Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. | Q38472164 |
| | Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome. | Q39549411 |
| | Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. | Q39577216 |
| | The RNA subunit of telomerase is encoded by Marek's disease virus | Q39748978 |
| | Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. | Q40275399 |
| | Analysis of a bovine herpesvirus 1 recombinant virus that does not express the bICP0 protein | Q40408696 |
| | Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. | Q40435095 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 1307-1317 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis | |
| P478 | volume | 203 | |